Sort
130,381 grants matching “hiv”
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women
$829,735Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2010 · HL
Reducing Arterial Inflammation and Improving Metabolic Health by Dual CCR2 and CCR5 Antagonism in People Living with HIV
$829,709Janet Lo · Massachusetts General Hospital · R01 · FY2020 · HL
Biophotonics
$829,707George Patterson · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2011 · EB
Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1
$829,628Jennifer M Lund · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
HCV Transmission among Young IDUs in NYC
$829,591Brian R. Edlin · Suny Downstate Medical Center · R01 · FY2011 · DA
Defining and then Maximizing the Footprint of CTL Selection on HIV Integration Site Landscapes to Optimize Cure Strategies
$829,575R. Brad Jones · Weill Medical Coll Of Cornell Univ · R37 · FY2025 · AI
Understanding Patient, Provider, and Systems Stakeholder Attitudes and Preferences to Optimize Implementation of Long-Acting Injectable Antiretrovirals and Maximize Clinical and Public Health Impact
$829,528Katerina A Christopoulos · University Of California, San Francisco · R01 · FY2020 · MH
Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation
$829,507Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2015 · AI
HIV-1 Env protein structure and function assessed by parallel smFRET and cryoET
$829,461Walther H Mothes · Yale University · R37 · FY2023 · AI
A randomized clinical trial of client-centered care coordination to improve pre-exposure prophylaxis use for Black men who have sex with men
$829,448Darren Lovell Whitfield · University Of Maryland Baltimore · R01 · FY2023 · MH
Limiting HIV establishment and maintenace by preserving intestinal immunity
$829,440Siddappa N Byrareddy · University Of Nebraska Medical Center · R01 · FY2018 · AI
A universal MHC-E-restricted T cell vaccine for HIV
$829,438Jonah B. Sacha · Oregon Health & Science University · R01 · FY2016 · AI
Role of intestinal microfold (M) cells in creating a hotspot environment for HIV reservoir persistence and reactivation
$829,396German Gustavo Gornalusse · University Of Washington · R01 · FY2024 · AI
HERPESVIRUS-ASSOCIATED MALIGNANCIES IN HIV PATIENTS
$829,337Johns Hopkins University · P01 · FY2003 · CA
Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection.
$829,283Cecile Tremblay · Centre Hospitalier De L'Universite De Montreal (University Of Montreal Hospital) · R01 · FY2025 · AG
Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV
$829,262Rachel Lena Rutishauser · University Of California, San Francisco · R01 · FY2024 · AI
Defining HIV reservoirs that rebound following suspension of ART
$829,247Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2017 · AI
Role of the innate immune defenses in viral infections
$829,217Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2022 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2023 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2019 · AI
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
$829,172Rebecca Schnall · Columbia University Health Sciences · R01 · FY2019 · MH
PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus
$829,151Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2022 · AI